S9 Ep3: FDA Approval Insights: Olaparib Plus Abiraterone in BRCA-Mutated mCRPC
Jun 15, 2023
12:18
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Armstrong discusses the FDA approval of olaparib plus abiraterone in patients with BRCA-mutated mCRPC, key efficacy and safety data from the PROpel trial, and where the field of prostate cancer research may be headed in the future.
OncLive® On Air